Physician

Arvind Chaudhry, MD

According to 2025 Medicare claims, Arvind Chaudhry, MD (NPI: 1750336236) practices hematology/oncology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 99208-1129. Chaudhry is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621) and Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Chaudhry's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 972 traditional Medicare patients, billed 299,162 HCPCS/CPT codes, and received $7,256,486 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,083 prescription claims across 321 beneficiaries totaling $8,759,050 in drug costs, led by Imbruvica (Ibrutinib). 2023 DME data shows 34 claims. Open Payments data shows 374 records totaling $956,520. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,180,637 to $7,256,486. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,234,468 and ending at $8,759,050. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $17,920 to $1,415.